## Acute Gout Attack Pathophysiology and Management ### Correct Statements (Options 0, 1, 3) **Key Point:** Monosodium urate (MSU) crystals deposited in the joint space activate the NLRP3 inflammasome in resident macrophages and monocytes. This leads to caspase-1 activation and IL-1β secretion, driving acute inflammation. [cite:Harrison 21e Ch 297] **High-Yield:** Colchicine is an anti-inflammatory agent that binds to β-tubulin and inhibits microtubule polymerization. This prevents neutrophil migration into the joint and blocks inflammasome assembly and IL-1β release. Colchicine is most effective when given early in the acute attack (within 12–24 hours of onset). [cite:KD Tripathi 8e Ch 12] **Clinical Pearl:** Febuxostat is a non-purine selective xanthine oxidase inhibitor approved as an alternative to allopurinol, particularly in patients with **allopurinol hypersensitivity** (especially those with HLA-B*5801 allele, common in East Asian and South Asian populations). It is an appropriate alternative in this clinical context. [cite:Harrison 21e Ch 297] ### Incorrect Statement (Option 2) — THE ANSWER **Warning:** Urate-lowering therapy (ULT) such as allopurinol or febuxostat should **NOT be initiated during an acute gout attack**. Rapid lowering of serum uric acid during an acute attack can paradoxically **worsen or prolong the attack** by mobilizing MSU crystals from tissues and joints, triggering further inflammation. **Key Point:** The correct management sequence is: 1. **Treat the acute attack first** with NSAIDs (indomethacin, naproxen), colchicine, or corticosteroids (oral or intra-articular). 2. **Wait 2–4 weeks after resolution** of the acute attack. 3. **Then initiate ULT** (allopurinol, febuxostat, or probenecid) at a low dose, with gradual titration to target serum uric acid < 6 mg/dL. 4. **Prophylaxis** with colchicine or NSAIDs should be given for 3–6 months alongside ULT initiation to prevent recurrent attacks. [cite:Harrison 21e Ch 297] **Mnemonic:** **ACUTE-THEN-LOWER** — Treat the **ACUTE** attack first; **THEN** start **LOWER**ing therapy after resolution. ## Management Algorithm for Acute Gout ```mermaid flowchart TD A[Acute gout attack]:::outcome --> B{Timing?}:::decision B -->|During acute attack| C[Treat inflammation first]:::action C --> D[NSAIDs, colchicine, or corticosteroids]:::action B -->|After resolution| E[Initiate ULT]:::action E --> F[Allopurinol or febuxostat]:::action F --> G[Target serum urate < 6 mg/dL]:::outcome C --> H[Wait 2-4 weeks]:::action H --> E E --> I[Prophylaxis with colchicine/NSAIDs for 3-6 months]:::action I --> J[Prevent recurrent attacks]:::outcome ``` ## Summary: Acute vs. Chronic Gout Management | Phase | Goal | Agents | Timing | | --- | --- | --- | --- | | **Acute attack** | Reduce inflammation | NSAIDs, colchicine, corticosteroids | Immediate | | **Post-acute (2–4 weeks)** | Lower uric acid | Allopurinol, febuxostat, probenecid | After attack resolves | | **Maintenance** | Prevent recurrence | ULT + prophylaxis | Long-term |
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.